Important Safety Information
Indications for Use (IFU): The MRIdian Linac system, with magnetic resonance imaging capabilities, is intended to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated. The MRIdian Linac System is not appropriate for all patients, including those who are not candidates for magnetic resonance imaging.
Important Safety Information (ISI): Radiation treatments may cause side effects that can vary depending on the part of the body being treated. The most frequent ones are typically temporary and may include, but are not limited to, irritation to the respiratory, digestive, urinary or reproductive systems; fatigue; nausea; skin irritation; and hair loss. In some patients, side effects can be severe. Treatment sessions may vary in complexity and duration.
Radiation treatment is not appropriate for all cancers. You should discuss the potential for side effects and their severity as well as the benefits of radiation and magnetic resonance imaging with your doctor to make sure radiation treatment is right for you.
Disclaimer: The opinions and clinical experiences presented herein are specific to the featured physicians and the featured patients and are for information purposes only. Nothing in this material is intended to provide specific medical advice or to take the place of written law or regulations. Results of treatment presented in the videos and information on this webpage are not indicative of typical or future results.
Discuss treatment options with your doctor, including the risks and benefits of the entire course of treatment specific to your individual needs. MRIdian Linac systems are only available at appropriately equipped facilities with specially trained physicians.
WEBINAR: "One and Done" Single Fraction: The Future of MR-Guided Lung Radiotherapy?
Safely treating lung tumors with ablative doses can be challenging, from central and ultra central to single fraction requires a new level of precision and accuracy. See how Amsterdam University Medical Center is using MRIdian to treat smarter with ablative doses that work harder to destroy tumors and spare healthy tissues. Join this webinar where they will share their experience treating lung cancer with single fraction SABR. With the potential to improve outcomes, reduce side effects and deliver better patient quality of life, is this the future of cancer care? Come see what you may be missing.
Prof. Suresh Senan, MD, Professor of Clinical Experimental Radiotherapy
Miguel Palacios, PhD, Medical Physicist
MRIdian In The News Related To Lung Cancer
The NewYork-Presbyterian Hospital and Weill Cornell Medicine - New York, NY - 2:09 minutes
MDs: Himanshu Nagar, MD and Nicholas Sanfilippo, MD
Producer: Fox5 News
Lung tumor, 5 days of radiation therapy
- Accurately hit a tumor with radiation, even with subtle patient movements (breathing, hiccups)
- Radiation is automatically turned off until tumor returns to exact position
- Protect healthy surrounding tissues from radiation
December 20, 2018
Henry Ford Cancer Institute - Cottage - Detroit, MI - 1:51 minutes
MDs: Benjamin Movsas, MD
Producer: Henry Ford TV
- Offers radiation oncologists the ability to see the exact location of the tumor in real-time using MRI
- Better radiation treatments will improve patients lives
- ViewRay technology fits with the focus on precision medicine; better targeting, precision radiation
July 16, 2019
UCLA Health, Jonsson Comprehensive Cancer Center - Los Angeles, CA - 3:15 minutes
MDs: Percy Lee, MD; Nzhde Agazaryan, PhD, DABR
Producer: UCLA Health
- “Adaptive radiotherapy”- patient therapy can be customized on a daily basis
- Better outcomes and reduction of side effects
- Increasing efficacy of radiation in getting rid of tumors
May 10, 2016
UCLA Health, Jonsson Comprehensive Cancer Center - Los Angeles, CA - 2:53 minutes
MDs: Percy Lee, MD; Minsong Cao, PhD
Producer: UCLA Health
- Department is proud to acquire most advanced technology to benefit patients (2015)
- For the first time, we can visualize the tumor while radiation treatment is going on
- Usually rely on CT scan and fiducials but organs move and cannot adjust for movement in real-time, you can with ViewRay
- “Gated” treatment: radiation will only occur when tumor is exactly at radiation target site
- Amazed by quality of images which will change the way we deliver radiation: personalized for patients needs
January 9, 2015
News Articles Related To Lung Cancer
February 1, 2017
Scientific Presentations Related To Lung Cancer
Advantages of Low Field Strength for RT
John Bayouth, PhD
Carbone Cancer Center, University of Wisconsin – Madison
Dr. Bayouth has been compensated by ViewRay for his services in preparing and presenting this material for ViewRay’s further use and distribution.
The Emerging Role of Online Adaptive Radiotherapy in the Treatment of Lung Cancer
Lauren Henke, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Dr. Henke has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.
3 Years of Experience with MR-IGRT at Washington University
Vivian Rodriguez, Ph.D.
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine – St. Louis, MO
Dr. Rodriguez has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.
Low field MRI on Viewray MRIdian
Yingli Yang, Ph.D.
UCLA Health, Jonsson Comprehensive Cancer Center – Los Angeles, CA
Dr. Yang has been compensated by ViewRay for her services in preparing and presenting this material for ViewRay’s further use and distribution.
Videos Related To Lung Cancer
RayZR Double Focused MLC
Image and treat simultaneously with MRIdian® because organ motion matters!
June 13, 2018
MRIdian Linac Technology Overview
Introducing MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously.
June 13, 2018